Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I’ve been barking back at dbagmiller for years. He’s always got the bitter beer angle going and only appears when pps is rag dolled and no news
our company
Regulatory capture can sometimes be a form of financial engineering.
Yes, I do find it interesting, as I like to learn as much as I can. I just don't like it being done with our company.
I also stop checking whether the deck is stacked, once I take a seat and start actually playing.
I don't really enjoy speculating about all the financial engineering stuff (when it has to do with my investment).
I just have this nagging feeling that Denner doesn't care
https://cafc.uscourts.gov/home/oral-argument/scheduled-cases/
For anyone tracking Amarin v Hikma.
When the oral arguments are scheduled, it will show up here.
Sleven,
KNJS, Don't remember those predictions, but it sounds like the guy.
Sleven,
He had the DOW at 19k in late 2020 and his baby SMSI at a minimum of $25 by the end of 2021…
They are currently 34k and $1.18. Swing a miss! Woof.
Yes I get the reference. You are talking about th patriots comeback in the super bowl . I know my sports.
LOL he is a golfer you clown I know exactly who he is.
Captain, Thanks for the numbers.
Sleven,
VASCEPA, Leader of the Pack!
https://drive.google.com/file/d/15lbBm9X1UfH3Ln47CSa5r3YRVJYI0m9l/view?usp=sharing
I've been busy most of the day but here's my Scripts report for Week Ending 9/15/23:
Takeaways:
* Total Market at All-Time-High (181,403, Slide #2)
* VASCEPA narrowing the gap with generic Lovaza (Slide #1)
* All products up for the week, VASCEPA leads the pack with 14.47% increase (+8264)! (Slide#3)
* VASCEPA increases market share vs. generic VASCEPA (58.02% vs. 41.92%, Slide#4)
* Q3 will top Q2 in total scripts (Slide#5)
* September is on track to be VASCEPA's best month (Slide#6)
Caddiedad, I think he also predicted that by now our market would be completely gone due to the generic hoard. Just another windbag, Endless opinions based on minimal research.
Sleven,
Our resident professor of Confirmation Bias, dr.Miller would say we all are doomed and that our future is undeserving by dollar cost averaging in uncertain times and lower prices. Such a condescending character.
Do we have a Tom Brady on our team, or a Bill Belichick coaching us?
Of course he doesn’t, you could give him a clue of Pats and he’d still need to phone a friend. He got my ignore list a long time ago. He probably has no idea who Seve Ballesteros is, either, but he knows all things AMRN? Tiring
Tke, Thank you. Good luck in NWBO.
Enjoy your weekend.
Sleven,
Thanks. Truly, you are one of the reasons I read this board. No emotion, just pragmatic commentary.
I’m so heavy in this, I’ve said I’m done adding. However, if NWBO keeps up the current move, I may rethink that. Lol.
Best to you and have a great weekend!
Tke, You and me both brother. I will continue to add to my position as funds allow. There is quite a bit going on right now. Most just can't see it.
Sleven,
Kiwi, I have no access to graphs and charts. That's a Captain thing. V scripts are still less than L. The gap is shrinking.i am sure Captain will post his report later today.
Sleven,
Thanks slev. and for all that you do.
Still around and holding strong. Not that this price action is fun. The selling pressure is palpable but I remain undeterred.
Sweep sweep
I hear the sweepers coming
Capt / N7 Do you still have the long term graphs of total Lovaza and total Vascepa ( brand and generic ) ?
And is there anyway to produce a graph of Vascepa vs Lovaza in the UK .
Total V scripts are now greater than total L scripts in the US aren't they ?
I'm just wondering if we will see a similar trend in the UK
Kiwi
Right, I think there's still a path to a reasonable valuation without BRAVE (securing reimbursement in Germany, France, Italy and continuing to stabilize the US market). BRAVE would be a massive bonus though.
I had hopes for the AHA latebreakers to keep us afloat in the near term until these longer term goals are secured. Some last thoughts on MITIGATE, we don't know if Ambrosy submitted but got rejected, or if he didn't attempt a submission at all. Whatever "medical embargo" there was on the results, there's no reason now to withhold any of the data.
So you don't get the reference. :)
Seve, you are getting exhausting.
If brave does not hit the only real hope is for a long slow climb up as revenue slowly moves up the next few years. With only one drug sadly all our eggs are in one basket. The whole theory that denner wanted a quick sale seems out the window be very hard to sell a .90 cent stock for more than a few bucks a share. I don’t think there is anyway he could currently get 5 a share for the company imo. Maybe 3 right now max. I think we are in for a long road of several years before a sale even remotely seems possible.
Laurent. thx for updating us
Kiwi
Seve, hopefully you get the reference.
Putting all this hope in brave seems like an all or nothing proposition to me. Most of these trials fail so I am not expecting much but I guess if we ever want this stock to go over ten bucks something like that is probably the only hope.
Thats it feels more like 56-3. Now we are just praying the stock can get back to a buck in the next 24 days.
Tke, Good to hear from you. Up w/w and y/y.
Sleven,
Thanks Slev. Definitely a positive just hope discounts are being managed as best they can
And it's all your fault
I just keep telling myself, we're down 28-3.
That's unfortunate. Thanks for staying on top of this, Laurent.
Actually, all the late breakers are out, doesn't seem like MITIGATE or any other IPE trials are on there (nothing in featured science either). The trials are all listed, but some of them are not yet confirmed. Might explain the slump yesterday. Seems like it's all up to BRAVE now.
https://professional.heart.org/en/meetings/scientific-sessions/programming/late-breaking-science#late-breaking
From Raf and Captain.
V 65,387. +8,264
Gv 47,199 +2,807
L 68,816. +5,590
Sleven,
Or a medical device, like the Cope Button IT REELY CLEENS UP MUH BORD
It is pretty clear denner has no issue with this stock being undr a buck nor with getting a nasdaq letter in 23 days. Will take some pretty darn big news to get this back ove a buck again imo.
Will buy a chunk when it gets back to 1.10.We are being shorted by people we know and they have contact with big funds but I think Denner knows how to play this game and it may go to 74 cents but when Denner just dipped his toes with a 4m buy to see who the enemy is and Alex will come good ,Patience not fear
They are the Deplorables!
Whereas you come here despite having something better to do?
Prescription numbers look good this week. Thanks raf.
Sleven,
0.8937-0.0156 (-1.7156%)
As of 10:24AM EDT. Market open.
Denner wants to take this private I have no doubt. His goal is to suck the life out of retail and until we all throw our hands up and give up. He can then come in with a joke of a price like 2 bucks and people will say ok I give up.
Sadly as i said we will hit .85 cents today. Once you go uner a buck the shorts just hammer a stock big time. But hey i am told not to worry over a few cents.
I dont think denner cares about the science in the least even brave. I think brave is being way overhyped and will be a non event honestly. Unless he takes this private I think denner is lookking to get a BO at 5 or 6 bucks honestly cause that is probably all he can get at best. I really dont think denner wants to sit around for another two years waiting on some sales in europe that barely tick up. The stock is in the toilet and not good results in the third quarter will drive it down either futher. I think denner knows eurpoe is basically a loser as far as revenue growth and will sell or go private soon within the next 6 months.
Followers
|
1087
|
Posters
|
|
Posts (Today)
|
66
|
Posts (Total)
|
415782
|
Created
|
03/12/07
|
Type
|
Free
|
Moderators ziploc_1 zmanindc johnhancoque golf stud tm100 Number sleven |
AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote
Y! Finance AMRN Landing Page
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page